A. Fujimori et al., SILENCING AND SELECTIVE METHYLATION OF THE NORMAL TOPOISOMERASE-I GENE IN CAMPTOTHECIN-RESISTANT CEM C2 HUMAN LEUKEMIA-CELLS/, Oncology research, 8(7-8), 1996, pp. 295-301
Camptothecin resistance of the human leukemia CEM/C2 cells is associat
ed with a topoisomerase I (top1) mutation: Asn722Ser (Fujimori, A. et
al. Cancer Res. 55:1339-1346; 1995). The corresponding DNA point mutat
ion generates a novel site for the restriction endonuclease DdeL. We f
ound that only the mutated top1 transcript was detectable in CEM/C2 by
reverse transcriptase-polymerase chain reaction. Genomic DNA analysis
by Southern blotting with DdeI showed that both the mutated and norma
l top1 genes were present in CEM/C2 cells. The mechanism of normal top
1 allele silencing was further investigated. Cytogenetic analysis with
a human chromosome 20 specific probe and restriction mapping by South
ern blotting showed that both cell lines had a similar copy number of
chromosome 20, with the predominant population containing 5-6 copies,
and no detectable top1 gene rearrangement. Southern blotting using met
hylcytosine-sensitive restriction endonuclease (HpaII) indicated diffe
rential top1 methylation in CEM/C2 cells. Global cytosine methylation,
however, appeared similar in CEM/C2 and wild-type CEM cells. These re
sults indicate that gene-specific DNA methylation can play a role in d
ownregulating top1 gene(s) and in the cellular resistance to camptothe
cins. Copyright (C) 1996 Elsevier Science Inc.